Neurocrine Biosciences
NBIX
#1386
Rank
S$17.09 B
Marketcap
$168.84
Share price
-1.18%
Change (1 day)
12.71%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of September 2024 : S$1.65 Billion

According to Neurocrine Biosciences 's latest financial reports the company has S$1.65 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$1.36 B2.73%
2022-12-31S$1.32 B37.92%
2021-12-31S$0.96 B-9.25%
2020-12-31S$1.05 B17.23%
2019-12-31S$0.90 B1.65%
2018-12-31S$0.88 B28.87%
2017-12-31S$0.69 B55.13%
2016-12-31S$0.44 B-17.07%
2015-12-31S$0.53 B109.45%
2014-12-31S$0.25 B38.69%
2013-12-31S$0.18 B-12.73%
2012-12-31S$0.21 B26.55%
2011-12-31S$0.16 B2.31%
2010-12-31S$0.16 B117.72%
2009-12-31S$75.05 M-34.78%
2008-12-31S$0.11 B-55.42%
2007-12-31S$0.25 B-7.81%
2006-12-31S$0.28 B-38.41%
2005-12-31S$0.45 B-7.45%
2004-12-31S$0.49 B-36.19%
2003-12-31S$0.76 B81.33%
2002-12-31S$0.42 B-28.32%
2001-12-31S$0.59 B107.55%
2000-12-31S$0.28 B88.16%
1999-12-31S$0.15 B685.24%
1998-12-31S$19.31 M-27.49%
1997-12-31S$26.63 M68.45%
1996-12-31S$15.81 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.08 B-34.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.37 B 43.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$12.81 M-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.73 B 186.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.80 B 493.24%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.38 B 710.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.33 B-79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.37 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA